Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. A Double Blind, Randomised, Placebo Controlled Trial.

NCT04248179 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT04248179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04248179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. A Double Blind, Randomised, Placebo Controlled Trial.
Lead sponsor
Zealand University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 29, 2019
Completion date
December 8, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ductal carcinoma in situ